Postherpetic neuralgia (PHN) is still intractable, regardless of the multifaceted therapy available. Our department examined 58 cases of pain after herpes zoster. The patients received the first medical examination over 3 months after development of symptoms. Postherpetic pain continued for 3-5 months in 12 cases, PHN developed 6 months later in 46 cases. Pain relief was reported in 7 cases (58.3%) from the postherpetic pain group, and in 14 cases (30.4%) from the PHN group. Five cases (41.7%) and 6 cases (13.0%) , respectively were completed. We mainly applied the nerve block to the postherpetic pain and PHN. The 58 cases/patients included those that underwent multifaceted therapy previously, those that stopped treatment voluntarily, and those that rejected treatment out of fear of it being harmful. Thus, the above results suggest that multifaceted therapy for PHN has limitations.
Moreover, we evaluated the curative effects, not by the drug therapy, but by the nerve block, thermocoagulation, and spinal cord stimulation, among various treatments for PHN. Although there are some cases in which thermocoagulation and spinal cord stimulation are effective, further examination is needed to analyze the problems and issues over a long period of time.
Markedly progressed therapy for PHN has not been found yet. Rather than a single kind of treatment, the multifaceted therapy is mainly utilized at present. It is important to choose the treatments which aim for the maintenance and improvement in ADL and/or QOL for each case.
View full abstract